Amedica rebrands as Sintx Technologies

Amedica (NSDQ:AMDA) said this week that it’s rebranding as Sintx Technologies to better reflect its core silicon nitride business.

The Salt Lake City-based company said it plans to change its trading symbol on the NASDAQ exchange to “SINT” in early November.

“The previous name, i.e., Amedica, has transferred to CTL Medical, which is now CTL-Amedica. Our new corporate brand reflects both our core competence in the science and production of silicon nitride ceramics, as well as encouraging prospects for the future, as an OEM supplier of spine implants to CTL-Amedica, and several opportunities outside of spine,” chairman & CEO Dr. Sonny Bal said in prepared remarks. “As Sintx Technologies, we will focus on developing silicon nitride in terms of product design, and future biomaterial formulations, for a variety of OEM customers.”

Last month Amedica closed the sale of its spine business to CTL Medical for $10 million, making CTL the exclusive owner of its Taurus, Preference and Valeo implants. Amedica kept the manufacturing, R&D and intellectual property rights for its core silicon nitride tech.

The post Amedica rebrands as Sintx Technologies appeared first on MassDevice.

from MassDevice https://ift.tt/2DjwhhB